Although the overall reduction in Parkinson’s disease risk did not reach statistical significance, semaglutide users exhibited a notable protective effect with a relative risk of 0.574.
← all excerpts
Innovative Diabetes Therapies and Impact on Peripheral and Autonomic Diabetic Neuropathies: A State-of-the-Art Review.
1
—
—